Global Nucleic Acid Amplification Market – Industry Trends and Forecast to 2030

 Nucleic Acid Amplification Market Analysis and Size

According to the World Health Organization's October 2021 report, tuberculosis is prevalent in all countries and age groups, and approximately 10 million people became ill with tuberculosis (TB) worldwide in 2020, with eight countries accounting for two-thirds of total TB cases, with India leading the count, followed by China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa. Furthermore, according to the Joint United Nations Program on HIV/AIDS (UNAIDS) fact sheet Global HIV and AIDS Statistics 2021, 37.7 million people worldwide were living with HIV in 2020. As a result, the rising prevalence of infectious diseases is expected to drive market growth.

Data Bridge Market Research analyses that the nucleic acid amplification market which is USD 3.27 billion in 2022, is expected to reach USD 6.66 billion by 2030, at a CAGR of 9.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nucleic Acid Amplification Market Scope and Segmentation  

Market Definition

A Nucleic Acid Amplification Test, or NAAT, is a type of viral diagnostic test for the virus that causes COVID-19, SARS-CoV-2. NAATs recognize genetic material (nucleic acids). NAATs for SARS-CoV-2 specifically identify the RNA (ribonucleic acid) sequences that make up the virus's genetic material. SARS-CoV-2 NAATs examine specimens from the upper or lower respiratory tract. The type of specimen collected during SARS-CoV-2 testing is determined by the test being performed and the manufacturer's instructions. Collecting and Handling of Clinical Specimens for COVID-19 Testing by the CDC

Nucleic Acid Amplification Market Dynamics

Drivers

• Growing demand for INAAT products

To meet the growing demand for INAAT offerings, key players are expanding their product portfolio by introducing advanced reagents for the most recent INAAT products. For instance, Thermo Fisher Scientific, Inc. released its Invitrogen Super Script IV RT-LAMP Master Mix for the detection of various viral pathogens in March 2022. Such product launches boost market growth by expanding the utility of INAAT techniques across a wide range of applications.

• Rise in cancer cases

According to the American Cancer Society, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States in 2020, with 606,520 people dying from the disease. The growing cancer burden increases the demand for diagnostic tests such as NAAT. Furthermore, the Hepatitis Foundation estimates that up to 2.2 million people will be chronically infected with Hepatitis B in 2021, but only 25% of those infected will be diagnosed. As a result of the growing need for better diagnostic tests in the regions, major players and the government are focusing on emerging technologies with higher efficacy, such as nucleic acid amplification testing.

Opportunities

• Technological Developments

A few of the country's key market players are developing advanced diagnostics kits to compete with existing products, while others are acquiring and partnering with other market players. For instance, in March 2022, Thermo Fisher Scientific introduced two novel reverse transcription loop-mediated isothermal amplification (RT-LAMP)-based solutions to support ongoing viral infection research and surveillance, including SARS-CoV-2. While PCR remains the gold standard for diagnostic, lab-based testing, isothermal RT-LAMP nucleic-acid based amplification provides a quick and cost-effective option for identifying viral infections. Such developments are bolstering the region's market growth.

Restraints/Challenges

• High cost of tonometer devices

High cost of nucleic acid amplification and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate.

This nucleic acid amplification market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nucleic acid amplification market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Nucleic Acid Amplification Market

COVID-19 has boosted market growth by increasing demand for rapid and accurate testing alternatives for detecting the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and obtained emergency use approvals from the US FDA for such products. For instance, Grifols Diagnostic Solutions Inc.'s Procleix SARS-CoV-2 assay and Lucira Health, Inc.'s Lucira CHECK-IT COVID-19 test kit, are commercially available products in this domain. Such COVID-19-fueled strategic initiatives are likely to provide a significant boost to market growth in the near future.

Recent Developments

• In 2022, The US Food and Drug Administration granted Emergency Use Authorization to Abbott's ID Now COVID-19 2.0 quick point-of-care test. The test is performed using the company's ID Now technology, which employs isothermal nucleic acid amplification to detect infectious illnesses qualitatively.
• In 2020, Abbott received FDA approval for the emergency use of ID NOW COVID-19, a nucleic acid amplification test (NAAT), an isothermal, rapid system for qualitatively detection of COVID-19.

Global Nucleic Acid Amplification Market Scope

The nucleic acid amplification market is segmented on the basis of application and technique. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Infectious Diseases
• Cancer
• Personalized Medicine
• Genetic

Technique

• Target Amplification
• Probe Amplification
• Signal Amplification

Nucleic Acid Amplification Market Regional Analysis/Insights

The nucleic acid amplification market is analyzed and market size insights and trends are provided by country, application and technique as referenced above.

The countries covered in the nucleic acid amplification market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The nucleic acid amplification market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nucleic acid amplification market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nucleic acid amplification market. The data is available for historic period 2011-2021.

Competitive Landscape and Nucleic Acid Amplification Market Share Analysis

The nucleic acid amplification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nucleic acid amplification market.

Some of the major players operating in the nucleic acid amplification market are:

• Siemens (Germany)
• Hologic, Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Abbott (U.S.)
• BD (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• NeuroLogica Corp. (U.S.)
• Shimadzu Medical (India) pvt. Ltd. (Japan)
• General Electric (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Sysmex India Pvt. Ltd. (Japan)
• Hitachi, Ltd. (Japan)
• Canon Inc. (Japan)
• FUJIFILM Holdings Corporation (U.K.)

SKU-59350